For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
For decades, scientists have investigated the neurokinin-1 receptor (NK1R) as a potential target for treating major ...
The paper, titled, "Weekly Subcutaneous VK2735, a GIP/GLP-1 Receptor Dual Agonist, for Weight Management: Phase 2, Randomized, 13-Week VENTURE Study," was published in Obesity, the peer-reviewed ...
Touch a hot plate and your hand flies back. While the response is almost instant, researchers are still working to better understand the molecular mechanisms behind these sensations of heat and pain.
A genetic mutation passed from mother to children in families affected by schizophrenia has now been shown to completely ...
ZÜRICH, SWITZERLAND / ACCESSWIRE / December 3, 2024 / NLS Pharmaceutics Ltd. (NASDAQ:NLSP)(NASDAQ:NLSPW) (NLS), a biopharmaceutical company, is pleased to share preclinical data demonstrating the ...
Kanazawa University, in collaboration with Osaka University and the National Institutes for Quantum Science and Technology, ...
A Dartmouth study is the first to identify a neural receptor that promotes psilocybin's therapeutic benefits for depression and anxiety without the hallucinogenic side effects. The findings provide a ...
FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback